Back to Rankings

BN

BrookfieldB
NYSE / Financial Services
Last Price
At close
2026-06-02
View Chart

AI scenario view

RankAlpha Sentiment CodexPost-earnings T+1
B+
Bull case
0%
Probability
Target price
$61.00
+33.8% vs current
Most likely
B
Base case
0%
Probability
Target price
$53.77
+17.9% vs current
B-
Bear case
0%
Probability
Target price
$40.00
-12.3% vs current

AI sentiment snapshot

Latest data as of 2026-05-29
Recent news sentiment (30D)
+18.4
Positive
Company
+23.6
Positive
Macro
+18.7
Positive
Pulse
-32.0
Negative
Sentiment proxy
+64.2
Score

AI commentary

Tone is mildly positive: Brookfield's primary release and Reuters-syndicated follow-up both read constructive, but the beat was modest and the packet lacks broad analyst revision evidence. Peer framing is improved by using direct alternatives comparators rather than generic financials, but BN's structure remains less clean than KKR, BX, or APO. With no social-context signal and no options/short-interest readthrough, this remains a monitoring-style positive rather than a strong re-rating call.

RankAlpha Sentiment Codex - 2026-05-29
Open post-earnings memo

Evidence flagged

peer set is too generic or lacks enough direct operating comparators

Impact
tentative
Confidence
-

AI events

2026-05-14eventQ1 beat and premarket reactionMedium impact

Brookfield reported Q1 distributable earnings of $1.6B ($0.66/share) versus $1.4B ($0.59/share) in distributable earnings before realizations, and Reuters-syndicated coverage said the stock traded about 2% higher premarket after the release; the company also highlighted more than $1B of YTD BN/BAM repurchases [#PR-BN-Q1-2026].

2026-06-30catalystLarge buyback pace supports downsideMedium impact

Management said BN and BAM had repurchased over $1B of shares year-to-date, including $470M of BN, while keeping the quarterly dividend at $0.07/share; that capital-return signal helps absorb volatility if growth is merely steady [#PR-BN-Q1-2026].

2026-09-30catalystBN/BNT simplification could unlock capital efficiencyMedium impact

The company is advancing plans to combine BN and its insurance business BNT, aiming to improve capital efficiency and deployment flexibility, while fee-bearing capital reached $614B and asset-management results grew 11%; this is the main longer-horizon re-rate lever [#PR-BN-Q1-2026].

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo
As of 2026-05-29 • Updated nightlySource: Internal modelMethodology